Insider Transactions Reported by 15 Insiders of Alto Neuroscience, Inc.

Symbol
ANRO on NYSE
Location
Mountain View, CA

There are no Buy or Sell transactions made by insiders since 19 Mar 2025

Alto Neuroscience, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Amit Etkin PRESIDENT AND CEO, Director $24,296,455 01 Mar 2026
Nicholas Conrad Smith Chief Financial Officer & Cbo $473,741 01 Mar 2026
Andrew Dreyfus Director $96,920 13 May 2025
Husseini Manji Director $94,972 02 Jan 2026
Christopher Nixon Cox Director $84,973 02 Jan 2026
Gwill York Director $61,972 02 Jan 2026
Ramiro Sanchez Director $44,986 02 Jan 2026
Maha Radhakrishnan Director $5,040 08 Mar 2024
Po Yu (jeff) Chen Director $4,882 06 Feb 2024
Alpha Wave Ventures GP, Ltd 10%+ Owner 01 Feb 2024
Adam Savitz Chief Medical Officer 11 Feb 2026
ALKEON CAPITAL MANAGEMENT LLC Director, Other* 01 Feb 2024
Apeiron Investment Group Ltd. Other* 06 Feb 2024
Alpha Wave Global, LP 10%+ Owner 06 Feb 2024
Jr. Michael Conick Hanley Chief Operating Officer 11 Feb 2026

Recent Insider Transactions by Companies or Individuals for Alto Neuroscience, Inc.

Showing up to 300 most recent insider transactions from the last 12 months.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
Amit Etkin ANRO Common Stock Tax liability -0.5% -6,227 1,233,949 01 Mar 2026 Direct
Nicholas Conrad Smith ANRO Common Stock Tax liability -10.4% -2,806 24,060 01 Mar 2026 Direct
Amit Etkin ANRO Employee Stock Option (Right to Buy) Award 306,000 306,000 11 Feb 2026 Direct
Adam Savitz ANRO Employee Stock Option (Right to Buy) Award 124,000 124,000 11 Feb 2026 Direct
Nicholas Conrad Smith ANRO Employee Stock Option (Right to Buy) Award 200,000 200,000 11 Feb 2026 Direct
Jr. Michael Conick Hanley ANRO Employee Stock Option (Right to Buy) Award 131,000 131,000 11 Feb 2026 Direct
Gwill York ANRO Stock Option (right to buy) Award 5,243 5,243 02 Jan 2026 Direct
Christopher Nixon Cox ANRO Stock Option (right to buy) Award 7,189 7,189 02 Jan 2026 Direct
Husseini Manji ANRO Employee Stock Option (right to buy) Award 4,228 4,228 02 Jan 2026 Direct
Ramiro Sanchez ANRO Stock Option (right to buy) Award 3,806 3,806 02 Jan 2026 Direct
Ramiro Sanchez ANRO Stock Option (right to buy) Award 34,502 30,574 12 Aug 2025 Direct
Jr. Michael Conick Hanley ANRO Employee Stock Option (Right to Buy) Disposed to Issuer -100% -321,000 0 03 Jul 2025 Direct
Jr. Michael Conick Hanley ANRO Employee Stock Option (Right to Buy) Award 321,000 188,000 03 Jul 2025 Direct
Adam Savitz ANRO Employee Stock Option (Right to Buy) Disposed to Issuer -100% -76,000 0 03 Jul 2025 Direct
Adam Savitz ANRO Employee Stock Option (Right to Buy) Disposed to Issuer -100% -252,134 0 03 Jul 2025 Direct
Adam Savitz ANRO Employee Stock Option (Right to Buy) Award 328,134 123,645 03 Jul 2025 Direct
Amit Etkin ANRO Employee Stock Option (Right to Buy) Disposed to Issuer -100% -215,000 0 03 Jul 2025 Direct
Amit Etkin ANRO Employee Stock Option (Right to Buy) Disposed to Issuer -100% -504,910 0 03 Jul 2025 Direct
Amit Etkin ANRO Employee Stock Option (Right to Buy) Award 719,910 247,290 03 Jul 2025 Direct
Nicholas Conrad Smith ANRO Employee Stock Option (Right to Buy) Disposed to Issuer -100% -135,000 0 03 Jul 2025 Direct
Nicholas Conrad Smith ANRO Employee Stock Option (Right to Buy) Disposed to Issuer -100% -371,124 0 03 Jul 2025 Direct
Nicholas Conrad Smith ANRO Employee Stock Option (Right to Buy) Award 506,124 202,329 03 Jul 2025 Direct
Husseini Manji ANRO Stock Option (right to buy) Award 15,287 15,287 13 May 2025 Direct
Christopher Nixon Cox ANRO Stock Option (right to buy) Award 15,287 15,287 13 May 2025 Direct
Andrew Dreyfus ANRO Stock Option (right to buy) Award 15,287 15,287 13 May 2025 Direct
Gwill York ANRO Stock Option (right to buy) Award 15,287 15,287 13 May 2025 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.